Thermo Fisher Scientific Announces Oncomine Clinical Research ...

The program aims to assist educational and independent research projects that exhibit excellence in molecular profiling to advance clinical ...

San Diego Biotech Networks on X: "Thermo Fisher Scientific ...

Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Awardees, Including First Recipients in India and the Netherlands ...

Thermo Fisher Scientific's Post - LinkedIn

Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Awardees and Opens Spring 2023 Submissions · More from this author · Explore ...

Thermo Fisher Scientific Introduces Oncomine Clinical Research ...

As part of an initial pilot focused on oncology, the company is calling for proposals dedicated to gene fusions in solid tumors and molecular testing in ...

Thermo Fisher Scientific Announces Next-Generation Sequencing ...

With the increasing importance of genetic translocations in oncology, the Oncomine Focus Assay enables clinical research laboratories to include ...

Oncomine Clinical Research Grant Program | Thermo Fisher Scientific

To support clinical research needs using next-generation sequencing (NGS), Thermo Fisher Scientific today announced it is accepting new submissions for its ...

Oncomine Clinical Research Grant Program - Thermo Fisher Scientific

Oncomine Clinical Research Grant Program ... We and our affiliates and vendors use cookies and similar technologies to operate our sites, recognize visitors to ...

Thermo Fisher Scientific Introduces Oncomine Clinical Research ...

CARLSBAD, Calif., Sept. 23, 2020 /PRNewswire/ -- Thermo Fisher Scientific today introduced the Oncomine Clinical Research Grant Program to ...

Thermo Fisher Scientific Oncomine Clinical Research Grant Program

A PURCHASE OR PAYMENT. WILL NOT IMPROVE YOUR CHANCES OF WINNING. 1. HOW TO APPLY: To participate in the Thermo Fisher Scientific Oncomine Clinical Research ...

Thermo Fisher Scientific Announces Next-Generation Sequencing ...

Thermo Fisher Scientific Announces Next-Generation Sequencing Oncomine Focus Assay for Oncology Research. Translational and clinical research laboratories ...

Lab Bulletin on X: "Thermo Fisher Scientific Announces Oncomine ...

Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Awardees https://t.co/AWClX9F0pW.

FDA Approves Thermo Fisher Oncomine Dx Target Test as CDx for ...

Thermo Fisher Scientific said Monday that its Ion Torrent Oncomine Dx Target test has received approval from the US Food and Drug Administration.

Thermo Fisher seeks grant proposals that leverage NGS

... Oncomine Clinical Research Grant ... Thermo Fisher Scientific announced that it has launched two new products.

Thermo Fisher Scientific announces FDA approval for NGS-based ...

Thermo Fisher Scientific this week announced that its Oncomine Dx Target Test has received approval as a companion diagnostic (CDx) from the ...

Oncomine Assays for Oncology Research - Thermo Fisher Scientific

Conduct concurrent DNA and RNA NGS analysis from FFPE samples, targeting 143 cancer genes relevant to clinical cancer research. Detect SNVs, indels, CNVs, and ...

Thermo Fisher Scientific to Help Advance Myeloid Cancer Clinical ...

Thermo Fisher collaborates with NCI to advance AML and MDS treatments using next-gen sequencing. Discover how this trial offers personalized ...

Thermo Fisher's Oncomine gains FDA approval as brain tumor ...

Thermo Fisher Scientific has announced that its in vitro diagnostic test, Oncomine ... Save hours of research. Gain competitive edge. View ...

New Oncomine Childhood Cancer Research Assay Launched by ...

... clinical next-generation sequencing and oncology at Thermo Fisher Scientific. “We are pleased to have partnered with Children's Hospital Los ...

Thermo Fisher Scientific Expands Oncomine Portfolio for Liquid ...

In addition to the new pan-cancer product, the Oncomine liquid biopsy portfolio for clinical research includes five single-indication-focused ...

Thermo Fisher Scientific Signs New Agreements to Expand ...

Daiichi Sankyo and Takeda Pharmaceuticals to leverage FDA-approved test for clinical trials and drug development programs.